Chargement en cours...
Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myeloma
We studied 190 patients with smoldering multiple myeloma (SMM) at our institution between 1973 and 2014. Evolving change in monoclonal protein level (eMP) was defined as ⩾10% increase in serum monoclonal protein (M) and/or immunoglobulin (Ig) (M/Ig) within the first 6 months of diagnosis (only if M-...
Enregistré dans:
| Publié dans: | Blood Cancer J |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5030386/ https://ncbi.nlm.nih.gov/pubmed/27471870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2016.65 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|